CompanyScope

Dexcom, Inc. income statement & cash flow

Ticker DXCM · SEC CIK 1093557 · Latest fiscal year ended Dec 31, 2025

In the fiscal year ended Dec 31, 2025, Dexcom, Inc. reported net income of $836.30M on revenue of $4.66B. Operating cash flow was $1.44B and capital expenditures were $363.50M, leaving $1.08B of free cash flow (operating cash flow minus capital expenditures).

−$250M$0$250M$500M$750M$1BDec 2016: −$65.60MDec 2017: −$50.20MDec 2018: −$127.10MDec 2019: $101.10MDec 2020: $549.70MDec 2021: $216.90MDec 2022: $341.20MDec 2023: $541.50MDec 2024: $576.20MDec 2025: $836.30MDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Dexcom, Inc. net income by fiscal year, USD. Hover a bar for the exact figure.

Income statement and cash flow summary

Fiscal year endedDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue (USD)$573.30M$718.50M$1.03B$1.48B$1.93B$2.45B$2.91B$3.62B$4.03B$4.66B
Gross profit (USD)$378.40M$492.10M$663.90M$931.50M$1.28B$1.68B$1.88B$2.29B$2.44B$2.80B
Operating income (USD)−$63.90M−$42.50M−$186.30M$142.30M$299.50M$265.80M$391.20M$597.70M$600.00M$911.80M
Net income (USD)−$65.60M−$50.20M−$127.10M$101.10M$549.70M$216.90M$341.20M$541.50M$576.20M$836.30M
Diluted EPS (USD per share)—−$0.58−$1.44$1.10$1.33$0.53$0.82$1.30$1.42$2.09
Operating cash flow (USD)$56.20M$92.00M$123.20M$314.50M$475.60M$442.50M$669.50M$748.50M$989.50M$1.44B
Capital expenditures (USD)$55.70M$66.00M$67.10M$180.00M$199.00M$389.20M$364.80M$236.60M$358.80M$363.50M
Reported in10-K 201910-K 202010-K 202110-K 202210-K 202310-K 202410-K 202510-K 202610-K 202610-K 2026

Columns are fiscal years, labeled by the month the year ended; scroll sideways on small screens. — means the company did not report the figure under the XBRL concepts we track.

Margins

Each figure divided by revenue for the same fiscal year.

Fiscal year endedGross marginOperating marginNet margin
Dec 202560.1%19.6%17.9%
Dec 202460.5%14.9%14.3%
Dec 202363.2%16.5%14.9%
Dec 202264.7%13.4%11.7%
Dec 202168.6%10.9%8.9%
$0$500M$1B$2BDec 2016: $56.20MDec 2017: $92.00MDec 2018: $123.20MDec 2019: $314.50MDec 2020: $475.60MDec 2021: $442.50MDec 2022: $669.50MDec 2023: $748.50MDec 2024: $989.50MDec 2025: $1.44BDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Dexcom, Inc. operating cash flow by fiscal year, USD. Hover a bar for the exact figure.

Source: SEC EDGAR XBRL company facts for CIK 1093557 (raw data). Most recent filing in this dataset: 10-Q filed Oct 29, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.